Literature DB >> 12018779

A random-effects mixture model for classifying treatment response in longitudinal clinical trials.

W Xu1, D Hedeker.   

Abstract

A random-effects regression model that allows the random coefficients to have a multivariate normal mixture distribution is described for classifying treatment response in longitudinal clinical trials. The proposed model is capable of dealing with longitudinal data from unknown heterogeneous populations. As applied to longitudinal clinical trials, for example, the model can distinguish subgroups of treatment response. Use of the proposed model is illustrated by analyzing data from two psychiatric clinical trials. The first includes depressed patients assigned to drug treatment who are repeatedly measured in terms of their level of depression. The second trial examined schizophrenic patients longitudinally who were assigned to either a drug or placebo condition. For both, the random-effects mixture model allows an assessment of whether patients comprise distinct populations in terms of their treatment response. Based on parameter estimates of the mixture model, ample evidence for a mixture of response to treatment is observed for both datasets.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12018779

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  13 in total

1.  Methods for testing theory and evaluating impact in randomized field trials: intent-to-treat analyses for integrating the perspectives of person, place, and time.

Authors:  C Hendricks Brown; Wei Wang; Sheppard G Kellam; Bengt O Muthén; Hanno Petras; Peter Toyinbo; Jeanne Poduska; Nicholas Ialongo; Peter A Wyman; Patricia Chamberlain; Zili Sloboda; David P MacKinnon; Amy Windham
Journal:  Drug Alcohol Depend       Date:  2008-01-22       Impact factor: 4.492

2.  Nonlinear random-effects mixture models for repeated measures.

Authors:  Casey L Codd; Robert Cudeck
Journal:  Psychometrika       Date:  2013-12-12       Impact factor: 2.500

3.  Cognitive decline in the elderly: an analysis of population heterogeneity.

Authors:  Kathleen M Hayden; Bruce R Reed; Jennifer J Manly; Douglas Tommet; Robert H Pietrzak; Gordon J Chelune; Frances M Yang; Andrew J Revell; David A Bennett; Richard N Jones
Journal:  Age Ageing       Date:  2011-09-02       Impact factor: 10.668

4.  A Finite Mixture of Nonlinear Random Coefficient Models for Continuous Repeated Measures Data.

Authors:  Nidhi Kohli; Jeffrey R Harring; Cengiz Zopluoglu
Journal:  Psychometrika       Date:  2015-04-30       Impact factor: 2.500

5.  Repeated measures regression mixture models.

Authors:  Minjung Kim; M Lee Van Horn; Thomas Jaki; Jeroen Vermunt; Daniel Feaster; Kenneth L Lichstein; Daniel J Taylor; Brant W Riedel; Andrew J Bush
Journal:  Behav Res Methods       Date:  2020-04

6.  A Within-Subject Normal-Mixture Model with Mixed-Effects for Analyzing Heart Rate Variability.

Authors:  Jessica M Ketchum; Al M Best; Viswanathan Ramakrishnan
Journal:  J Biom Biostat       Date:  2012

7.  Joint modeling of survival time and longitudinal outcomes with flexible random effects.

Authors:  Jaeun Choi; Donglin Zeng; Andrew F Olshan; Jianwen Cai
Journal:  Lifetime Data Anal       Date:  2017-08-30       Impact factor: 1.588

8.  Estimating drug effects in the presence of placebo response: causal inference using growth mixture modeling.

Authors:  Bengt Muthén; Hendricks C Brown
Journal:  Stat Med       Date:  2009-11-30       Impact factor: 2.373

9.  Evaluating differential effects using regression interactions and regression mixture models.

Authors:  M Lee Van Horn; Thomas Jaki; Katherine Masyn; George Howe; Daniel J Feaster; Andrea E Lamont; Melissa R W George; Minjung Kim
Journal:  Educ Psychol Meas       Date:  2014-10-28       Impact factor: 2.821

10.  Modelling human immunodeficiency virus ribonucleic acid levels with finite mixtures for censored longitudinal data.

Authors:  Bettina Grün; Kurt Hornik
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2012-03       Impact factor: 1.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.